Clinical Trial Update: Safety and Tolerability of PRO-155 Ophthalmic Solution 0.09% in Healthy Volunteers. [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating safety and tolerability of PRO-155 ophthalmic solution 0.09% in healthy volunteers with completed results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cataract
• Inflammation

Drugs mentioned

• PRO-155 ophthalmic solution 0.09%

Snippet

Sponsor: Laboratorios Sophia S.A de C.V. | Conditions: Inflammation, Cataract | Phase 1 | Status: COMPLETED | Results posted: 2019-07-19